ACTRN12605000657628招募中4 期
A Multi-Centre, Open label Study to Investigate the Recovery of Interferon-b Efficacy in Relapsing-Remitting Multiple Sclerosis Patients with Neutralising IFN-b Antibodies and Reduced Bioavailability.
Biogen Idec Australia Pty Ltd0 个研究点目标入组 20 人开始时间: 2005年10月18日最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 招募中
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Non-randomised trial
- 主要目的
- Treatment
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 18 Years 至 55 Years（—）
- 性别
- All
入选标准
- •Diagnosis of relapsing-remitting multiple sclerosis; treated with interferon-b; EDSS below 6.0; test positive for NABs (at least 20 via CPE assay or at least 100 via MxA protein assay) on two consecutive tests at least 3 months apart; reduced bioavailability as measured by MxA mRNA/GAPDH.
排除标准
- •No exclusion criteria
研究者
相似试验
已完成
3 期
A Phase III study of safety and efficacy of ligelizumab in the treatment of CSU iChronic Spontaneous UrticariaJPRN-jRCT208022463366
进行中（未招募）
不适用
Maintenance Study Including Re-induction Therapy for Patients Who Did Not Show a Clinical Effect in Study C87037 (2014-004399-42)EUCTR2014-004400-30-Outside-EU/EEACB Japan Co., Ltd.46
进行中（未招募）
不适用
A study to investigate the pharmacokinetics in children (aged 1 month to 17 years) with epilepsy, prescribed lacosamide.EpilepsyEUCTR2014-002629-36-Outside-EU/EEACB Biosciences, Inc32
进行中（未招募）
1 期
Study to investigate the effectiveness and safety of AOP Landiolol in controlling supraventricular tachycardia in children.Supraventricular tachycardia in pediatric patients.MedDRA version: 20.0Level: PTClassification code 10003658Term: Atrial fibrillationSystem Organ Class: 10007541 - Cardiac disordersMedDRA version: 20.0Level: PTClassification code 10074640Term: Junctional ectopic tachycardiaSystem Organ Class: 10007541 - Cardiac disordersMedDRA version: 20.0Level: PTClassification code 10042604Term: Supraventricular tachycardiaSystem Organ Class: 10007541 - Cardiac disordersMedDRA version: 20.0Level: PTClassification code 10003662Term: Atrial flutterSystem Organ Class: 10007541 - Cardiac disordersMedDRA version: 20.0Level: PTClassification code 10040752Term: Sinus tachycardiaSystem Organ Class: 10007541 - Cardiac disordersMedDRA version: 20.0Level: PTClassification code 10003668Term: Atrial tachycardiaSystem Organ Class: 10007541 - Cardiac disordersEUCTR2015-001129-17-DEAOP Orphan Pharmaceuticals GmbH60
进行中（未招募）
1 期
Study to investigate the effectiveness and safety of AOP Landiolol in controlling supraventricular tachycardia in children.Supraventricular tachycardia in pediatric patients.MedDRA version: 20.0Level: LLTClassification code 10003859Term: AV reentrant tachycardiaSystem Organ Class: 10007541 - Cardiac disordersMedDRA version: 20.0Level: PTClassification code 10003658Term: Atrial fibrillationSystem Organ Class: 10007541 - Cardiac disordersMedDRA version: 20.0Level: PTClassification code 10074640Term: Junctional ectopic tachycardiaSystem Organ Class: 10007541 - Cardiac disordersMedDRA version: 20.0Level: PTClassification code 10042604Term: Supraventricular tachycardiaSystem Organ Class: 10007541 - Cardiac disordersMedDRA version: 20.0Level: LLTClassification code 10052350Term: Multifocal atrial tachycardiaSystem Organ Class: 10007541 - Cardiac disordersMedDRA version: 20.0Level: PTClassification code 10003662Term: Atrial flutterSystem Organ Class: 10007541 - Cardiac disordersMedDRA version: 20.0Level: PTClassification code 10040752Term: Sinus tachycardiaSystem Organ Class: 10007541 - Cardiac disordersMedDRA version: 20.0Level: LLTClassification code 10003857Term: AV nodal reentrant tachycardiaSystem Organ Class: 10007541 - Cardiac disordersEUCTR2015-001129-17-LTAOP Orphan Pharmaceuticals AG60